AU7079098A - Pharmaceutical composition for supressing type 2 helper t cell immune respons - Google Patents

Pharmaceutical composition for supressing type 2 helper t cell immune respons

Info

Publication number
AU7079098A
AU7079098A AU70790/98A AU7079098A AU7079098A AU 7079098 A AU7079098 A AU 7079098A AU 70790/98 A AU70790/98 A AU 70790/98A AU 7079098 A AU7079098 A AU 7079098A AU 7079098 A AU7079098 A AU 7079098A
Authority
AU
Australia
Prior art keywords
supressing
helper
type
pharmaceutical composition
cell immune
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU70790/98A
Inventor
Yuso Goto
Hiroshi Ochi
Hideyuki Tomizawa
Takamasa Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharmaceuticals Co Ltd
Eneos Corp
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Japan Energy Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd, Japan Energy Corp filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of AU7079098A publication Critical patent/AU7079098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU70790/98A 1997-04-25 1998-04-22 Pharmaceutical composition for supressing type 2 helper t cell immune respons Abandoned AU7079098A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP9123146A JPH10298181A (en) 1997-04-25 1997-04-25 Type 2 helper t cell selective immune response inhibitor
JP9-123146 1997-04-25
PCT/JP1998/001841 WO1998048805A1 (en) 1997-04-25 1998-04-22 Pharmaceutical composition for supressing type 2 helper t cell immune response

Publications (1)

Publication Number Publication Date
AU7079098A true AU7079098A (en) 1998-11-24

Family

ID=14853339

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70790/98A Abandoned AU7079098A (en) 1997-04-25 1998-04-22 Pharmaceutical composition for supressing type 2 helper t cell immune respons

Country Status (4)

Country Link
EP (1) EP0977569A1 (en)
JP (1) JPH10298181A (en)
AU (1) AU7079098A (en)
WO (1) WO1998048805A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451810B1 (en) * 1999-06-10 2002-09-17 3M Innovative Properties Company Amide substituted imidazoquinolines
US6331539B1 (en) 1999-06-10 2001-12-18 3M Innovative Properties Company Sulfonamide and sulfamide substituted imidazoquinolines
US6756382B2 (en) 1999-06-10 2004-06-29 3M Innovative Properties Company Amide substituted imidazoquinolines
US6573273B1 (en) 1999-06-10 2003-06-03 3M Innovative Properties Company Urea substituted imidazoquinolines
US6541485B1 (en) 1999-06-10 2003-04-01 3M Innovative Properties Company Urea substituted imidazoquinolines
US6869956B2 (en) * 2000-10-03 2005-03-22 Bristol-Myers Squibb Company Methods of treating inflammatory and immune diseases using inhibitors of IκB kinase (IKK)
CA2475595C (en) * 2002-02-22 2012-07-10 3M Innovative Properties Company Method of reducing and preventing uvb-induced immunosuppression
MXPA06003705A (en) 2003-10-03 2006-06-20 3M Innovative Properties Co Alkoxy substituted imidazoquinolines.
MY146124A (en) * 2003-10-03 2012-06-29 3M Innovative Properties Co Pyrazolopyridines and analogs thereof
US8691837B2 (en) 2003-11-25 2014-04-08 3M Innovative Properties Company Substituted imidazo ring systems and methods
EP1844201B1 (en) 2005-02-04 2016-08-24 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
WO2007024707A2 (en) 2005-08-22 2007-03-01 The Regents Of The University Of California Tlr agonists
WO2007142755A2 (en) 2006-05-31 2007-12-13 The Regents Of The University Of California Purine analogs
BRPI0807196A2 (en) 2007-02-07 2014-06-03 Univ California METHOD TO PREVENT OR INHIBIT A BACTERIAL, VACCINE, COMPOUND INFECTION, AND METHOD TO PREVENT, TREAT OR INHIBIT ASTHMA
AU2009205700A1 (en) * 2008-01-15 2009-07-23 Dow Pharmaceutical Sciences, Inc. Imiquimod formulation
EP2363148B1 (en) * 2008-10-31 2014-11-26 Japan Science and Technology Agency Method for selectively controlling function of helper t cell
WO2010088924A1 (en) 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1271477A (en) * 1983-11-18 1990-07-10 John F. Gerster 1h-imidazo[4,5-c]quinolin-4-amines
HU222251B1 (en) * 1991-03-01 2003-05-28 Minnesota Mining And Manufacturing Company 1-and 2-substituted 1h-imidazo[4,5-c]quinolin-4-(substituted) derivatives for producing 1-and 2-substitute 1h-imidazo[4,5-c]quinolin-4-amine derivatives
US5268376A (en) * 1991-09-04 1993-12-07 Minnesota Mining And Manufacturing Company 1-substituted 1H-imidazo[4,5-c]quinolin-4-amines

Also Published As

Publication number Publication date
WO1998048805A1 (en) 1998-11-05
JPH10298181A (en) 1998-11-10
EP0977569A1 (en) 2000-02-09

Similar Documents

Publication Publication Date Title
AU7572196A (en) Pharmaceutical formulations
EG23826A (en) Pharmaceutical formulations
AU6216296A (en) Pharmaceutical compositions
AU3049397A (en) Cyclosporin-containing pharmaceutical composition
EP1001813B8 (en) Pharmaceutical formulations containing voriconazole
AU7079098A (en) Pharmaceutical composition for supressing type 2 helper t cell immune respons
AU6011496A (en) Improved pharmaceutical compositions for gene therapy
AU6740298A (en) Pharmaceutical composition
AU4762797A (en) Pharmaceutical compositions
AU2967597A (en) Pharmaceutical compositions
AU8107998A (en) Pharmaceutical compositions
AU3777897A (en) Pharmaceutical compositions
AU5317598A (en) Novel pharmaceutical compositions
AU5155096A (en) Pharmaceutical composition
EG24294A (en) Pharmaceutical compositions
AU7904998A (en) Pharmaceutical composition containing peptichemio
AU5274096A (en) Pharmaceutical compositions
ZA96525B (en) Novel pharmaceutical compositions
ZA96526B (en) Novel pharmaceutical formulation
AU1509799A (en) Pharmaceutical composition containing cyclosporin
AU4326197A (en) Pharmaceutical compositions
AU4457597A (en) Pharmaceutical compositions
AUPN862596A0 (en) Pharmaceutical compositions
AU1427895A (en) Pharmaceutical compositions
AU1544195A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase